Tension Headache: When to See a Doctor

At a glance
- Tension-type headache (TTH) affects up to 78% of the general population at some point in life
- Episodic TTH occurs fewer than 15 days per month; chronic TTH occurs 15 or more days per month
- Bilateral, pressing or tightening quality, mild to moderate intensity
- Not aggravated by routine physical activity (distinguishes it from migraine)
- Red flags include thunderclap onset, focal neurologic signs, fever, papilledema, or new headache after age 50
- First-line acute treatment: ibuprofen 400 mg or acetaminophen 1 to 000 mg
- Chronic TTH first-line preventive: amitriptyline 10 to 75 mg nightly
- Medication-overuse headache develops with analgesic use on 15 or more days per month
- Diagnosis is clinical; imaging is only needed when red flags are present
What Exactly Is a Tension-Type Headache?
Tension-type headache is the most common primary headache disorder worldwide, yet it receives far less clinical research attention than migraine. The International Headache Society (IHS) classifies it as a bilateral, non-pulsating headache of mild to moderate intensity that lasts 30 minutes to 7 days and is not worsened by walking or climbing stairs [1].
The Global Burden of Disease 2019 study ranked TTH as the third most prevalent condition on the planet, affecting roughly 2.98 billion episodes annually [2]. Despite those numbers, fewer than one in five people with frequent TTH ever discuss the problem with a physician, according to a Danish population study published in Cephalalgia [3]. That gap matters. Chronic TTH (defined as 15 or more headache days per month for at least three months) carries measurable disability: a 2008 analysis in The Journal of Headache and Pain found that chronic TTH patients lost an average of 27.4 workdays per year to headache-related disability [4].
The typical presentation feels like a band or cap squeezing both sides of the head. Nausea is absent or minimal. Photophobia or phonophobia may be present, but not both simultaneously, and vomiting essentially rules out pure TTH [1]. Pain intensity sits in the mild-to-moderate range, which is precisely why many people dismiss it and delay seeking care.
Why Do Tension Headaches Happen?
The cause is not a single mechanism. Current evidence points to a combination of peripheral myofascial factors and central sensitization, with the balance shifting as episodic TTH progresses toward chronic TTH.
In episodic TTH, pericranial muscle tenderness is the most consistent finding. A controlled study by Bendtsen and colleagues showed that patients with frequent episodic TTH had significantly higher pericranial tenderness scores than headache-free controls (P < 0.001), measured by manual palpation and pressure algometry [5]. Sustained contraction of the temporalis and trapezius muscles, often linked to postural strain, screen time, or psychosocial stress, generates nociceptive input that the trigeminal nucleus processes as headache pain.
As headache frequency climbs, central sensitization takes over. Bendtsen's research group demonstrated that chronic TTH patients show generalized lowering of pressure-pain thresholds, not only in pericranial muscles but also in the Achilles tendon and the tibialis anterior, locations far from the head [5]. This widespread hypersensitivity points to impaired supraspinal pain modulation rather than a local muscle problem.
Other contributing triggers include:
- Sleep disruption. Both short sleep (<6 hours) and irregular schedules increase headache frequency [6].
- Caffeine withdrawal. Abrupt cessation after habitual intake of 200 mg or more daily can trigger TTH within 12 to 24 hours [7].
- Psychological stress. A prospective diary study in Neurology found that stress was the most commonly reported trigger, cited in 80% of TTH episodes [8].
- Eyestrain and ergonomic factors. Prolonged near-focus work without breaks raises pericranial muscle tension measurably [9].
Genetics also play a role. A twin study from the Danish Twin Registry reported a heritability estimate of 48% for chronic TTH [10].
Red Flags: When a Tension Headache Needs Urgent Attention
The majority of tension headaches are benign. A small fraction, however, share surface features with dangerous secondary headaches. The American Headache Society and the International Headache Society recommend urgent evaluation when any of the following red flags appear [1][11]:
Thunderclap onset. A headache reaching maximal intensity within 60 seconds demands emergency assessment for subarachnoid hemorrhage. CT head sensitivity for subarachnoid hemorrhage is approximately 98% within 6 hours of onset, but drops to 93% by 24 hours, making lumbar puncture necessary if imaging is negative and clinical suspicion remains high [12].
Focal neurologic deficits. New weakness on one side of the body, speech difficulty, visual field loss, or ataxia accompanying a headache suggests stroke, mass lesion, or other structural pathology.
Fever with neck stiffness. This combination raises concern for meningitis or encephalitis and warrants blood cultures, lumbar puncture, and empiric antibiotics before imaging in many clinical algorithms.
New headache after age 50. Giant cell arteritis (temporal arteritis) should be excluded. The American College of Rheumatology recommends checking erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP); ESR above 50 mm/h combined with new temporal headache has a sensitivity of approximately 84% for giant cell arteritis [13].
Progressive worsening over weeks. A headache that intensifies steadily, particularly with morning nausea or positional features, may reflect raised intracranial pressure from a mass or idiopathic intracranial hypertension.
Headache after trauma. Post-traumatic headache following a blow to the head, even a seemingly minor one, warrants medical evaluation to exclude intracranial hemorrhage, especially in patients on anticoagulants.
Personality or cognitive change. Subtle behavioral shifts accompanying headache can indicate frontal lobe pathology.
The mnemonic SNOOP4 (Systemic symptoms, Neurologic signs, Onset sudden, Older age, Pattern change/Positional/Precipitated by Valsalva/Papilledema) captures these warning signs efficiently. Dr. David Dodick of the Mayo Clinic, who developed the SNOOP framework, has stated: "The purpose of SNOOP is to ensure that no dangerous secondary headache is missed during the initial clinical encounter" [11].
When to Book a Routine (Non-Emergency) Doctor Visit
Not every visit needs to be an emergency department trip. You should schedule an appointment with a primary care provider or headache specialist if:
- Headaches occur on 15 or more days per month for three months or longer. This meets the IHS definition of chronic TTH and typically benefits from preventive medication rather than repeated acute treatment [1].
- You are taking over-the-counter pain relievers on 10 to 15 or more days per month. This threshold signals risk for medication-overuse headache, a secondary headache disorder that paradoxically worsens pain when analgesics are used too frequently [14]. The International Headache Society defines the cutoff as 15 days per month for simple analgesics and 10 days per month for combination analgesics or triptans [1].
- Your headache pattern has changed. A lifelong episodic pattern that shifts to daily or near-daily frequency, or headaches that develop new features like aura, unilateral throbbing, or autonomic symptoms, should prompt re-evaluation.
- Over-the-counter treatment no longer works. Loss of analgesic efficacy may indicate central sensitization or medication overuse, both of which respond better to preventive strategies.
- Headaches are affecting your job, relationships, or mood. The WHO ranks chronic TTH among the top ten causes of disability globally [2]. If headache days are eroding your quality of life, a clinician can offer treatments that evidence shows reduce headache frequency by 50% or more.
How Tension Headache Is Diagnosed
Diagnosis is entirely clinical. No blood test or imaging study confirms TTH. The clinician applies the ICHD-3 criteria: at least 10 episodes of headache lasting 30 minutes to 7 days, bilateral location, pressing or tightening quality, mild to moderate intensity, and not aggravated by routine physical activity such as walking [1].
The examination focuses on identifying or excluding red flags. Fundoscopy checks for papilledema. Neurologic examination assesses cranial nerves, motor strength, reflexes, coordination, and gait. Palpation of pericranial muscles (frontalis, temporalis, masseter, sternocleidomastoid, trapezius, and suboccipital insertions) documents tenderness, which correlates with headache frequency [5].
Imaging is not routinely recommended. The American College of Radiology Appropriateness Criteria give MRI of the brain a "usually not appropriate" rating for adults presenting with a primary headache pattern and normal neurologic examination [15]. Ordering an MRI for every tension headache wastes resources and may generate incidental findings that trigger unnecessary anxiety. The guideline specifies imaging only when red flags are present or when the clinical picture is atypical.
A headache diary kept for at least four weeks before the clinic visit provides the single most useful piece of diagnostic data. Recording headache days, pain intensity on a 0-to-10 scale, medication use, and potential triggers allows the clinician to distinguish episodic from chronic TTH and detect medication overuse.
Evidence-Based Treatment for Tension Headache
Acute Treatment
For infrequent episodic TTH, simple analgesics remain first-line. A Cochrane review of 23 trials (N = 8,079) found that ibuprofen 400 mg produced a pain-free response at 2 hours in 45.2% of participants versus 28.6% for placebo (NNT = 6.3) [16]. Acetaminophen 1 to 000 mg showed similar efficacy, with a 2-hour pain-free rate of 38.9% versus 28.9% for placebo (NNT = 10) in a separate Cochrane analysis [17].
Aspirin 1 to 000 mg is an alternative for patients without contraindications. Combination analgesics containing caffeine (e.g., acetaminophen 500 mg + aspirin 500 mg + caffeine 130 mg) show modestly better efficacy than either component alone, but carry higher risk of medication-overuse headache with regular use [7].
Triptans have no role in TTH. They target serotonin 5-HT1B/1D receptors involved in migraine pathophysiology and show no benefit over placebo in pure tension-type headache [1].
Preventive Treatment
Prevention is indicated when TTH occurs on 15 or more days per month or when acute medication use approaches overuse thresholds.
Amitriptyline is the best-studied preventive agent. A meta-analysis of six randomized controlled trials found that amitriptyline 25 to 75 mg nightly reduced headache frequency by an average of 4.8 days per month compared with placebo [18]. Starting dose is typically 10 mg at bedtime, titrated upward every one to two weeks. The analgesic effect is independent of its antidepressant action and occurs at lower doses.
Dr. Lars Bendtsen, a headache researcher at the Danish Headache Center, has noted: "Amitriptyline remains the drug of first choice for chronic tension-type headache based on the overall level of evidence, but its use is limited by side effects including dry mouth, daytime drowsiness, and weight gain" [5].
Venlafaxine (150 mg daily) showed efficacy in a 12-week randomized trial, reducing headache days by 50% or more in 56% of the treatment group versus 18% for placebo [19]. It serves as a second-line option when amitriptyline is not tolerated.
Mirtazapine (15 to 30 mg nightly) demonstrated benefit in a single RCT but has less supporting evidence than amitriptyline or venlafaxine [18].
Non-Pharmacologic Approaches
Physiotherapy targeting pericranial muscles, including manual therapy and specific neck exercises, reduced headache frequency by approximately 2 days per month in a randomized trial compared with usual care [20].
Cognitive behavioral therapy (CBT) addressing stress management and maladaptive pain responses showed durable reductions in headache frequency at 12-month follow-up when combined with amitriptyline, outperforming amitriptyline alone [21].
Acupuncture received a "conditionally recommended" rating from the AHS guidelines for chronic TTH, based on Cochrane evidence showing modest benefit over sham acupuncture (1 to 2 fewer headache days per month) [22].
EMG biofeedback, particularly of the frontalis muscle, has the longest evidence base among behavioral treatments for TTH. A meta-analysis reported a medium effect size (d = 0.41) for headache reduction compared with waiting-list controls [23].
Medication-Overuse Headache: The Hidden Trap
One of the most common reasons a tension headache patient ends up in a specialist's office is medication-overuse headache (MOH). Taking simple analgesics on 15 or more days per month, or combination analgesics or triptans on 10 or more days per month, for three months or longer can transform episodic headache into a daily or near-daily pattern [14].
The Danish population-based study estimated MOH prevalence at 1 to 2% of the general population, with higher rates among women and individuals with comorbid anxiety or depression [3]. Withdrawal of the overused medication is the primary treatment. Headache intensity typically worsens for 2 to 10 days after abrupt discontinuation before beginning to improve. A bridge strategy using a short course of naproxen 500 mg twice daily or a brief prednisone taper (5 to 7 days) can ease the withdrawal period.
Prevention of relapse requires education and limits on acute medication use to no more than 2 days per week.
Tension Headache vs. Migraine: Key Differences
Misclassification is common. A primary care study found that 76% of self-diagnosed "sinus headaches" actually met criteria for migraine [24]. The table below highlights the main clinical distinctions.
| Feature | Tension-type headache | Migraine | |---|---|---| | Location | Bilateral | Often unilateral | | Quality | Pressing, tightening | Pulsating, throbbing | | Intensity | Mild to moderate | Moderate to severe | | Worsened by activity | No | Yes | | Nausea / vomiting | Absent or minimal | Common | | Photo- and phonophobia | One may be present, not both | Both common | | Typical duration | 30 min to 7 days | 4 to 72 hours | | Aura | Never | Present in ~25% |
If your headaches include nausea, are worsened by bending over, and force you to lie down in a dark room, they are more likely migraine than TTH, even if you have always called them "tension headaches." Accurate classification matters because triptans and CGRP-targeted therapies work for migraine but not for TTH.
Frequently asked questions
›What causes tension headache?
›How is tension headache diagnosed?
›When should I worry about a tension headache?
›How long do tension headaches last?
›Can tension headaches be cured?
›What is the best over-the-counter medicine for tension headache?
›Can stress cause tension headaches?
›Is it safe to take ibuprofen every day for tension headache?
›Do tension headaches cause dizziness?
›Can tension headaches cause neck pain?
›What is the difference between a tension headache and a migraine?
›Should I get an MRI for tension headaches?
References
- Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1-211. https://pubmed.ncbi.nlm.nih.gov/29368949
- GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019. Lancet. 2020;396(10258):1204-1222. https://pubmed.ncbi.nlm.nih.gov/33069326
- Lyngberg AC, Rasmussen BK, Jørgensen T, Jensen R. Has the prevalence of migraine and tension-type headache changed over a 12-year period? A Danish population survey. Eur J Epidemiol. 2005;20(3):243-249. https://pubmed.ncbi.nlm.nih.gov/15921042
- Linde M, Gustavsson A, Stovner LJ, et al. The cost of headache disorders in Europe. Eur J Neurol. 2012;19(5):703-711. https://pubmed.ncbi.nlm.nih.gov/22136117
- Bendtsen L. Central sensitization in tension-type headache: possible pathophysiological mechanisms. Cephalalgia. 2000;20(5):486-508. https://pubmed.ncbi.nlm.nih.gov/11037746
- Rains JC. Sleep and headache. Curr Treat Options Neurol. 2008;10(1):55-66. https://pubmed.ncbi.nlm.nih.gov/18325300
- Diener HC, Gold M, Hagen M. Use of a fixed combination of acetylsalicylic acid, acetaminophen, and caffeine compared with acetaminophen alone in episodic tension-type headache. Cephalalgia. 2014;34(4):265-276. https://pubmed.ncbi.nlm.nih.gov/24108308
- Spierings EL, Ranke AH, Honkoop PC. Precipitating and aggravating factors of migraine versus tension-type headache. Headache. 2001;41(6):554-558. https://pubmed.ncbi.nlm.nih.gov/11437890
- Eltayeb S, Staal JB, Hassan A, de Bie RA. Work related risk factors for neck, shoulder and arms complaints. J Occup Rehabil. 2009;19(4):315-322. https://pubmed.ncbi.nlm.nih.gov/19685174
- Russell MB, Ostergaard S, Bendtsen L, Olesen J. Familial occurrence of chronic tension-type headache. Cephalalgia. 1999;19(4):207-210. https://pubmed.ncbi.nlm.nih.gov/10376163
- Dodick DW. Pearls: headache. Semin Neurol. 2010;30(1):74-81. https://pubmed.ncbi.nlm.nih.gov/20127585
- Perry JJ, Stiell IG, Sivilotti ML, et al. Sensitivity of computed tomography performed within six hours of onset of headache for diagnosis of subarachnoid haemorrhage. BMJ. 2011;343:d4277. https://pubmed.ncbi.nlm.nih.gov/21768192
- Hunder GG, Bloch DA, Michel BA, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 1990;33(8):1122-1128. https://pubmed.ncbi.nlm.nih.gov/2202311
- Diener HC, Dodick D, Evers S, et al. Pathophysiology, prevention, and treatment of medication overuse headache. Lancet Neurol. 2019;18(9):891-902. https://pubmed.ncbi.nlm.nih.gov/31174999
- American College of Radiology. ACR Appropriateness Criteria: Headache. 2019. https://www.acr.org/Clinical-Resources/ACR-Appropriateness-Criteria
- Derry S, Wiffen PJ, Moore RA. Ibuprofen for acute treatment of episodic tension-type headache in adults. Cochrane Database Syst Rev. 2015;(7):CD011474. https://pubmed.ncbi.nlm.nih.gov/26230487
- Derry S, Wiffen PJ, Moore RA. Paracetamol (acetaminophen) for acute treatment of episodic tension-type headache in adults. Cochrane Database Syst Rev. 2014;(6):CD010888. https://pubmed.ncbi.nlm.nih.gov/24942776
- Jackson JL, Shimeall W, Sessums L, et al. Tricyclic antidepressants and headaches: systematic review and meta-analysis. BMJ. 2010;341:c5222. https://pubmed.ncbi.nlm.nih.gov/20961988
- Zissis NP, Harmoussi S, Vlaikidis N, et al. A randomized, double-blind, placebo-controlled study of venlafaxine XR in out-patients with tension-type headache. Cephalalgia. 2007;27(4):315-324. https://pubmed.ncbi.nlm.nih.gov/17346304
- Castien RF, van der Windt DA, Grooten A, Dekker J. Effectiveness of manual therapy for chronic tension-type headache. Cephalalgia. 2011;31(2):133-143. https://pubmed.ncbi.nlm.nih.gov/20647241
- Holroyd KA, O'Donnell FJ, Stensland M, et al. Management of chronic tension-type headache with tricyclic antidepressant medication, stress management therapy, and their combination. JAMA. 2001;285(17):2208-2215. https://pubmed.ncbi.nlm.nih.gov/11325323
- Linde K, Allais G, Brinkhaus B, et al. Acupuncture for the prevention of tension-type headache. Cochrane Database Syst Rev. 2016;(4):CD007587. https://pubmed.ncbi.nlm.nih.gov/27092807
- Nestoriuc Y, Rief W, Martin A. Meta-analysis of biofeedback for tension-type headache. Pain. 2008;136(3):341-351. https://pubmed.ncbi.nlm.nih.gov/17764840
- Schreiber CP, Hutchinson S, Webster CJ, et al. Prevalence of migraine in patients with a history of self-reported or physician-diagnosed "sinus" headache. Arch Intern Med. 2004;164(16):1769-1772. https://pubmed.ncbi.nlm.nih.gov/15364670